{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 447997597
| IUPAC_name = [2-(carbamoyloxymethyl)-2-methylpentyl] N-butylcarbamate
| image = Tybamate.png
| width = 200

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 4268-36-4
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 20266
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 3875LLL8M8
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D06260
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 19092

<!--Chemical data-->
| C=13 | H=26 | N=2 | O=4 
| molecular_weight = 274.357 g/mol
|  smiles = CCCCNC(=O)OCC(C)(CCC)COC(=O)N
|  StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C13H26N2O4/c1-4-6-8-15-12(17)19-10-13(3,7-5-2)9-18-11(14)16/h4-10H2,1-3H3,(H2,14,16)(H,15,17)
|  StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = PRBORDFJHHAISJ-UHFFFAOYSA-N

}}

'''Tybamate''' ([[International Nonproprietary Name|INN]]; '''Solacen''', '''Tybatran''', '''Effisax''') is an [[anxiolytic]] of the [[carbamate]] family.<ref name="TaylorFrancis2000">{{cite book | title = Index Nominum 2000: International Drug Directory | url = https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA634 | date = January 2000 | publisher = Taylor & Francis | isbn = 978-3-88763-075-1 | page = 1077}}</ref> It is a [[prodrug]] for [[meprobamate]] in the same way as the better known drug [[carisoprodol]]. It has liver enzyme inducing effects similar to those of phenobarbital but much weaker.<ref>Segelman FH, Kelton E, Terzi RM, Kucharczyk N, Sofia RD. The comparative potency of phenobarbital and five 1,3-propanediol dicarbamates for hepatic cytochrome P450 induction in rats. ''Research Communications in Chemical Pathology and Pharmacology''. 1985 Jun;48(3):467-70.</ref>

==References==
{{Reflist}}


{{Anxiolytics}}
{{GABAAR PAMs}}

[[Category:Anxiolytics]]
[[Category:Carbamates]]
[[Category:Prodrugs]]
[[Category:GABAA receptor positive allosteric modulators]]


{{nervous-system-drug-stub}}